Literature DB >> 19410430

The Premorbid Adjustment Scale as a measure of developmental compromise in patients with schizophrenia and their healthy siblings.

D I Shapiro1, S Marenco, E H Spoor, M F Egan, D R Weinberger, J M Gold.   

Abstract

Schizophrenia is associated with subtle developmental compromise, but the degree to which this is also associated with heritability and genetic risk is uncertain. The goal of the current study was to investigate the childhood, adolescent, and early adulthood social and academic function of patients with schizophrenia, their healthy siblings, and normal controls, using the Premorbid Adjustment Scale (PAS). Generalized Estimating Equations were conducted to account for nesting of subjects within families. Patients (N=286) scored significantly worse than their healthy siblings (N=315) at every age period; siblings scored significantly worse than controls (N=261) at every age period. In probands, PAS scores got worse after early adolescence while control and proband scores improved after late adolescence. Furthermore, patient PAS scores significantly predicted the scores of their own discordant siblings in childhood and late adolescence. This effect approached significance in early adolescence and in the general scale. Thus, the most premorbidly impaired patients tended to have non-ill siblings with worse premorbid adjustment scores than the siblings of less impaired probands. The results suggest that both patients and many of their siblings share poor adjustment in childhood and adolescence, possibly due to shared genetic or environmental risk factors.

Entities:  

Mesh:

Year:  2009        PMID: 19410430      PMCID: PMC2702694          DOI: 10.1016/j.schres.2009.04.007

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  26 in total

1.  Spatial working memory deficits in adolescents at clinical high risk for schizophrenia.

Authors:  Christopher W Smith; Sohee Park; Barbara Cornblatt
Journal:  Schizophr Res       Date:  2006-01-31       Impact factor: 4.939

2.  Premorbid neurocognitive functioning in schizophrenia spectrum disorder.

Authors:  Holger J Sørensen; Erik L Mortensen; Josef Parnas; Sarnoff A Mednick
Journal:  Schizophr Bull       Date:  2006-01-25       Impact factor: 9.306

3.  Validity of the premorbid adjustment scale.

Authors:  N Brill; A Reichenberg; M Weiser; J Rabinowitz
Journal:  Schizophr Bull       Date:  2007-11-20       Impact factor: 9.306

4.  The Maudsley early onset schizophrenia study. Predictors of psychosocial outcome at 4-year follow-up.

Authors:  Nora S Vyas; Michael Hadjulis; Apostolos Vourdas; Patrick Byrne; Sophia Frangou
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-10       Impact factor: 4.785

5.  Measurement of premorbid adjustment in chronic schizophrenia.

Authors:  H E Cannon-Spoor; S G Potkin; R J Wyatt
Journal:  Schizophr Bull       Date:  1982       Impact factor: 9.306

6.  Sustained attention deficits in relation to psychometrically identified schizotypy: evaluating a potential endophenotypic marker.

Authors:  Diane C Gooding; Christie W Matts; Elizabeth A Rollmann
Journal:  Schizophr Res       Date:  2006-01-25       Impact factor: 4.939

7.  Premorbid intellectual functioning and risk of schizophrenia and spectrum disorders.

Authors:  Abraham Reichenberg; Mark Weiser; Asaf Caspi; Haim Y Knobler; Gad Lubin; Philip D Harvey; Jonathan Rabinowitz; Michael Davidson
Journal:  J Clin Exp Neuropsychol       Date:  2006-02       Impact factor: 2.475

8.  Premorbid adjustment in schizophrenia--an important aspect of phenotype definition.

Authors:  Christine Schmael; Alexander Georgi; Bertram Krumm; Christin Buerger; Monika Deschner; Markus M Nöthen; Thomas G Schulze; Marcella Rietschel
Journal:  Schizophr Res       Date:  2007-03-21       Impact factor: 4.939

9.  Symptomatic remission and social/vocational functioning in outpatients with schizophrenia: prevalence and associations in a cross-sectional study.

Authors:  Luis San; Antonio Ciudad; Enrique Alvarez; Julio Bobes; Inmaculada Gilaberte
Journal:  Eur Psychiatry       Date:  2007-09-27       Impact factor: 5.361

10.  Familial liability to schizophrenia and premorbid adjustment.

Authors:  Muriel Walshe; Mark Taylor; Katja Schulze; Elvira Bramon; Sophia Frangou; Daniel Stahl; Eugenia Kravariti; Eileen Daly; Paul Fearon; Robin M Murray; Colm McDonald
Journal:  Br J Psychiatry       Date:  2007-09       Impact factor: 9.319

View more
  9 in total

1.  Potentially important periods of change in the development of social and role functioning in youth at clinical high risk for psychosis.

Authors:  Eva Velthorst; Jamie Zinberg; Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Ricardo E Carrión; Andrea Auther; Barbara A Cornblatt; Thomas H McGlashan; Daniel H Mathalon; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Abraham Reichenberg; Carrie E Bearden
Journal:  Dev Psychopathol       Date:  2017-04-19

2.  Early determinants of four-year clinical outcomes in bipolar disorder with psychosis.

Authors:  Gabrielle A Carlson; Roman Kotov; Su-Wei Chang; Camilo Ruggero; Evelyn J Bromet
Journal:  Bipolar Disord       Date:  2012-02       Impact factor: 6.744

3.  Premorbid functional development and conversion to psychosis in clinical high-risk youths.

Authors:  Sarah I Tarbox; Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Robert Heinssen; Thomas H McGlashan; Scott W Woods
Journal:  Dev Psychopathol       Date:  2013-11

4.  Premorbid Adjustment and IQ in Patients With First-Episode Psychosis: A Multisite Case-Control Study of Their Relationship With Cannabis Use.

Authors:  Laura Ferraro; Caterina La Cascia; Diego Quattrone; Lucia Sideli; Domenica Matranga; Veronica Capuccio; Giada Tripoli; Charlotte Gayer-Anderson; Craig Morgan; Musa B Sami; Pak Sham; Lieuwe de Haan; Eva Velthorst; Hannah E Jongsma; James B Kirkbride; Bart P F Rutten; Alexander L Richards; Laura Roldan; Celso Arango; Miquel Bernardo; Julio Bobes; Julio Sanjuan; Jose Luis Santos; Manuel Arrojo; Ilaria Tarricone; Andrea Tortelli; Andrei Szöke; Cristina Marta Del-Ben; Jean-Paul Selten; Michael Lynskey; Peter B Jones; Jim Van Os; Daniele La Barbera; Robin M Murray; Marta Di Forti
Journal:  Schizophr Bull       Date:  2020-04-10       Impact factor: 9.306

5.  Childhood-onset schizophrenia: what do we really know?

Authors:  Jennifer Bartlett
Journal:  Health Psychol Behav Med       Date:  2014-07-15

6.  Familial and socioeconomic contributions to premorbid functioning in psychosis: Impact on age at onset and treatment response.

Authors:  Alex Hatzimanolis; Pentagiotissa Stefanatou; Emmanouil Kattoulas; Irene Ralli; Stefanos Dimitrakopoulos; Stefania Foteli; Ioannis Kosteletos; Leonidas Mantonakis; Mirjana Selakovic; Rigas-Filippos Soldatos; Ilias Vlachos; Lida-Alkisti Xenaki; Nikolaos Smyrnis; Nicholas C Stefanis
Journal:  Eur Psychiatry       Date:  2020-04-29       Impact factor: 5.361

7.  A 1.5-Year Longitudinal Study of Social Activity in Patients With Schizophrenia.

Authors:  Kazutaka Ohi; Chika Sumiyoshi; Haruo Fujino; Yuka Yasuda; Hidenaga Yamamori; Michiko Fujimoto; Tomiki Sumiyoshi; Ryota Hashimoto
Journal:  Front Psychiatry       Date:  2019-08-09       Impact factor: 4.157

8.  The Association between COMT, BDNF, and NRG1 and Premorbid Social Functioning in Patients with Psychosis, Their Relatives, and Controls.

Authors:  Muriel Walshe; Evangelos Vassos; Marco Picchioni; Madiha Shaikh; Timothea Toulopoulou; David Collier; Colm McDonald; Robin Murray; Elvira Bramon
Journal:  Scientifica (Cairo)       Date:  2012-05-21

9.  Association between mitochondrial DNA and cognitive impairment in schizophrenia: study protocol for a Mexican population.

Authors:  Dulce Dajheanne García-de la Cruz; Isela Esther Juárez-Rojop; Carlos Alfonso Tovilla-Zárate; José Jaime Martínez-Magaña; Alma Delia Genis-Mendoza; Humberto Nicolini; Thelma Beatriz González-Castro; Crystell Guadalupe Guzmán-Priego; Nancy Adanelly López-Martínez; Javier Antonio Hernández-Cisneros; Francisco Caballero-Prado
Journal:  Neuropsychiatr Dis Treat       Date:  2019-06-28       Impact factor: 2.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.